The present invention relates to compounds of formula I
wherein s, R
1a
and R
1
to R
3
are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
CYCLOHEXYL PIPERAZINYL METHANONE DERIVATIVES AND THEIR USE AS HISTAMINE H3 RECEPTOR MODULATORS
申请人:F.HOFFMANN-LA ROCHE AG
公开号:EP1976840A1
公开(公告)日:2008-10-08
[EN] CYCLOHEXYL PIPERAZINYL METHANONE DERIVATIVES AND THEIR USE AS HISTAMINE H3 RECEPTOR MODULATORS<br/>[FR] DÉRIVÉS DE MÉTHANONE DE TYPE CYCLOHEXYLE ET PIPÉRAZINYLE ET LEUR APPLICATION EN TANT QUE MODULATEURS DU RÉCEPTEUR H3 DE L'HISTAMINE
申请人:HOFFMANN LA ROCHE
公开号:WO2007080140A1
公开(公告)日:2007-07-19
[EN] The present invention relates to compounds of formula (I), wherein s, R1aand R1 to R3 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors. [FR] La présente invention concerne des composés de formule (I), où s, R1a et R1 à R3 sont tels que définis dans la description et les revendications, ainsi que les sels de qualité pharmaceutique desdits composés. Lesdits composés peuvent être employés dans le traitement et/ou la prévention de maladies liées à la modulation des récepteurs H3.
Cyclohexyl piperazinyl methanone derivatives
申请人:Nettekoven Matthias
公开号:US20070167436A1
公开(公告)日:2007-07-19
The present invention relates to compounds of formula I
wherein s, R
1a
and R
1
to R
3
are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.